644 related articles for article (PubMed ID: 29307600)
21. LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2α-ATF4-CHOP axis.
Yu XX; Zhu MY; Wang JR; Li H; Hu P; Qing YJ; Wang XY; Wang HZ; Wang ZY; Xu JY; Guo QL; Hui H
Acta Pharmacol Sin; 2021 Feb; 42(2):290-300. PubMed ID: 32747719
[TBL] [Abstract][Full Text] [Related]
22. The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.
Lian Y; Ding J; Zhang Z; Shi Y; Zhu Y; Li J; Peng P; Wang J; Fan Y; De W; Wang K
Tumour Biol; 2016 Jun; 37(6):7431-40. PubMed ID: 26678886
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma.
Chung JH; Kim DH; Kim YS; Son BS; Kim D; Hwang C; Shin D; Noh SG; Han JH; Kim DK; Kim JH; Koo JS; Chung HY; Yoon SH
Cell Physiol Biochem; 2018; 50(1):304-316. PubMed ID: 30282071
[TBL] [Abstract][Full Text] [Related]
24. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions.
Beesetti S; Mavuluri J; Surabhi RP; Oberyszyn TM; Tober K; Pitani RS; Joseph LD; Venkatraman G; Rayala SK
Oncogene; 2017 Nov; 36(44):6154-6163. PubMed ID: 28692051
[TBL] [Abstract][Full Text] [Related]
26. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
[TBL] [Abstract][Full Text] [Related]
27. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
28. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
[TBL] [Abstract][Full Text] [Related]
29. Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.
Yang T; Zhang W; Wang L; Xiao C; Guo B; Gong Y; Liang X; Huang D; Li Q; Nan Y; Xiang Y; Shao J
J Int Med Res; 2019 Jan; 47(1):481-493. PubMed ID: 30556447
[TBL] [Abstract][Full Text] [Related]
30. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
31. STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL.
Verma NK; Davies AM; Long A; Kelleher D; Volkov Y
Cell Mol Biol Lett; 2010 Jun; 15(2):342-55. PubMed ID: 20213502
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
[TBL] [Abstract][Full Text] [Related]
33. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
[TBL] [Abstract][Full Text] [Related]
34. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
35. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
[TBL] [Abstract][Full Text] [Related]
36. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma.
Rea B; Haun P; Emerson R; Vignali M; Farooqi M; Samimi S; Elenitsas R; Kirsch I; Bagg A
J Clin Pathol; 2018 Sep; 71(9):814-820. PubMed ID: 29636372
[TBL] [Abstract][Full Text] [Related]
37. Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling.
Zhang C; Li B; Zhang X; Hazarika P; Aggarwal BB; Duvic M
J Invest Dermatol; 2010 Aug; 130(8):2110-9. PubMed ID: 20393484
[TBL] [Abstract][Full Text] [Related]
38. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression.
Li M; Deng Y; Zhuo M; Zhou H; Kong X; Xia X; Su Z; Chen Q; Guo P; Mo P; Yu C; Li W
Theranostics; 2020; 10(19):8863-8879. PubMed ID: 32754284
[No Abstract] [Full Text] [Related]
39. Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma.
Kohnken R; McNeil B; Wen J; McConnell K; Grinshpun L; Keiter A; Chen L; William B; Porcu P; Mishra A
J Invest Dermatol; 2019 Sep; 139(9):1966-1974.e3. PubMed ID: 30876800
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
